175 related articles for article (PubMed ID: 17062690)
1. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
Spugnini EP; Cardillo I; Verdina A; Crispi S; Saviozzi S; Calogero R; Nebbioso A; Altucci L; Cortese G; Galati R; Chien J; Shridhar V; Vincenzi B; Citro G; Cognetti F; Sacchi A; Baldi A
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6133-43. PubMed ID: 17062690
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability.
Verdina A; Cardillo I; Nebbioso A; Galati R; Menegozzo S; Altucci L; Sacchi A; Baldi A
J Transl Med; 2008 May; 6():27. PubMed ID: 18498639
[TBL] [Abstract][Full Text] [Related]
3. Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums.
Khokhar NZ; She Y; Rusch VW; Sirotnak FM
Clin Cancer Res; 2001 Oct; 7(10):3199-205. PubMed ID: 11595715
[TBL] [Abstract][Full Text] [Related]
4. Novel therapy for malignant pleural mesothelioma based on anti-energetic effect: an experimental study using 3-Bromopyruvate on nude mice.
Zhang X; Varin E; Briand M; Allouche S; Heutte N; Schwartz L; Poulain L; Icard P
Anticancer Res; 2009 Apr; 29(4):1443-8. PubMed ID: 19414400
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
Varin E; Denoyelle C; Brotin E; Meryet-Figuière M; Giffard F; Abeilard E; Goux D; Gauduchon P; Icard P; Poulain L
Carcinogenesis; 2010 Jun; 31(6):984-93. PubMed ID: 20142415
[TBL] [Abstract][Full Text] [Related]
6. COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines.
O'Kane SL; Eagle GL; Greenman J; Lind MJ; Cawkwell L
Lung Cancer; 2010 Feb; 67(2):160-5. PubMed ID: 19450893
[TBL] [Abstract][Full Text] [Related]
7. Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.
Li Q; Kawamura K; Yamanaka M; Okamoto S; Yang S; Yamauchi S; Fukamachi T; Kobayashi H; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
Cancer Gene Ther; 2012 Mar; 19(3):218-28. PubMed ID: 22223137
[TBL] [Abstract][Full Text] [Related]
8. 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo.
Kazuno H; Fujioka A; Fukushima M; Wataya Y; Matsuda A; Sasaki T
Int J Oncol; 2009 May; 34(5):1373-80. PubMed ID: 19360349
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of CDDP and caffeine against human gastric cell line in vivo.
Takahashi M; Yanoma S; Yamamoto Y; Rino Y; Amano T; Imada T
Anticancer Res; 1998; 18(6A):4399-401. PubMed ID: 9891499
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
Shinomiya N; Shinomiya M; Wakiyama H; Katsura Y; Rokutanda M
Exp Cell Res; 1994 Feb; 210(2):236-42. PubMed ID: 8299722
[TBL] [Abstract][Full Text] [Related]
11. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
[TBL] [Abstract][Full Text] [Related]
12. Glycerol enhances CDDP-induced growth inhibition of thyroid anaplastic carcinoma tumor carrying mutated p53 gene.
Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Kanata H; Yane K; Hosoi H; Ohnishi T
Oncol Rep; 2004 Apr; 11(4):821-4. PubMed ID: 15010879
[TBL] [Abstract][Full Text] [Related]
13. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
14. [A case of malignant peritoneal mesothelioma successfully treated with carboplatin and paclitaxel].
Ogura O; Noguchi T; Nagata K; Noma H; Maemura M; Higashimoto M; Takebayashi Y; Maeda S
Gan To Kagaku Ryoho; 2006 Jul; 33(7):1001-4. PubMed ID: 16835497
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
Qamar L; Davis R; Anwar A; Behbakht K
Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines.
Toma S; Colucci L; Scarabelli L; Scaramuccia A; Emionite L; Betta PG; Mutti L
J Cell Physiol; 2002 Oct; 193(1):37-41. PubMed ID: 12209878
[TBL] [Abstract][Full Text] [Related]
18. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo.
Bardella C; Dettori D; Olivero M; Coltella N; Mazzone M; Di Renzo MF
Clin Cancer Res; 2007 Apr; 13(7):2191-8. PubMed ID: 17404103
[TBL] [Abstract][Full Text] [Related]
20. ZDHHC8 knockdown enhances radiosensitivity and suppresses tumor growth in a mesothelioma mouse model.
Sudo H; Tsuji AB; Sugyo A; Ogawa Y; Sagara M; Saga T
Cancer Sci; 2012 Feb; 103(2):203-9. PubMed ID: 22017350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
